FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 43598-561 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Generic namelansoprazole
Labeler / ManufacturerDr.Reddys Laboratories Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA210465
Dosage form / routeTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (30 mg/1)
Marketing started20210201
Marketing ended20260930
Package count1

External sources

Source: openFDA. Public-domain (CC0).